Extracorporeal membrane oxygenation (ECMO) technology has relative contraindications in haemorrhagic disease but remains an effective therapeutic option for the treatment of pulmonary haemorrhage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback